Position in JNJ
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$532,067
+$15,077 QoQ
Shares Held
2,095
-0.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#3,631
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 81%
Shared 19%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIRST FINANCIAL CORP /IN/ holds $10,663,305 across 12 Drug Manufacturers - General names. JNJ ranks #4 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,212 | $5,051,998 | |
| 2 | ABBV |
AbbVie Inc.
|
9,288 | $2,337,231 | |
| 3 | MRK |
Merck & Co., Inc.
|
11,730 | $1,507,305 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
2,095 | $532,067 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
8,635 | $497,548 | |
| 6 | NVO |
Novo Nordisk A S
|
6,470 | $310,171 | |
| 7 | PFE |
Pfizer Inc
|
10,210 | $245,856 | |
| 8 | NVS |
Novartis AG
|
599 | $93,875 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $532,067 | 2,095 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $516,990 | 2,115 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $451,978 | 2,184 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $405,328 | 2,186 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $364,461 | 2,386 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $475,629 | 2,868 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $453,383 | 3,135 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $441,937 | 2,727 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $640,619 | 4,383 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $470,931 | 2,977 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $560,658 | 3,577 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $551,354 | 3,540 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $614,410 | 3,712 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $584,195 | 3,769 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $699,886 | 3,962 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $649,029 | 3,973 | Shares | Defined | 2022-10-20 | |
| 2022-06-30 | $705,957 | 3,977 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $712,464 | 4,020 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $705,663 | 4,125 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $671,194 | 4,156 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $669,173 | 4,062 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $611,217 | 3,719 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $574,121 | 3,648 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $552,195 | 3,709 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $524,408 | 3,729 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $510,225 | 3,891 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||